Laryngeal paragangliomas are rare submucosal lesions that arise from paraganglion cells located in the false vocal fold and subglottic larynx. To date, 76 recognized cases have been reported in the world literature. Symptoms arise when the lesions become large enough to impair function. Supraglottic paragangliomas cause hoarseness and deglutition disorders, whereas subglottic tumors become symptomatic when they obstruct the airway. Evaluation of these tumors includes obtaining a complete history. Familial paragangliomas and hypertension should be sought but are rarely, if ever, associated with laryngeal paragangliomas. MRI can detect these lesions and permit characterization of the vascularity of the lesion. Adding 111In pentetreotide scanning can distinguish neuroendocrine tumors from other submucosal laryngeal lesions, making the preoperative diagnosis clearer and obviating the need for biopsy. The biggest dilemma regarding laryngeal paragangliomas is making the correct pathologic distinction between paraganglioma, typical carcinoid, atypical carcinoid and medullary thyroid cancer. Immunohistochemical markers, supplementing standard histopathologic evaluation, can distinguish paragangliomas from the aforementioned tumors. This distinction is critical as the prognosis for treated paragangliomas is excellent compared to that for other neuroendocrine neoplasms. Almost all alleged malignant paragangliomas of the larynx are in reality atypical carcinoid tumors that have been misdiagnosed. Treatment should always comprise excision. Thyrotomy has the best chance of achieving a sustained cure without damaging phonation or deglutition. Laser excision has been used successfully but there is no great experience with this modality. Surgery is preferable to radiation for paragangliomas in all locations but especially so in the larynx, due to issues such as swelling, airway protection and destruction of cartilage. With increased clinical suspicion and the use of modern imaging techniques, laryngeal paragangliomas should be routinely diagnosed and treated without loss of laryngeal functions.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00016480410017576DOI Listing

Publication Analysis

Top Keywords

laryngeal paragangliomas
16
paragangliomas
10
atypical carcinoid
8
laryngeal
7
tumors
5
laryngeal paraganglioma
4
paraganglioma updated
4
updated critical
4
critical review
4
review laryngeal
4

Similar Publications

Carotid body paragangliomas represent an uncommon neoplasm in dogs. The objective of this study was to report outcomes and complications associated with surgical excision of carotid body paragangliomas in 21 dogs. Cases were recruited retrospectively via medical record review from 9 veterinary speciality centres.

View Article and Find Full Text PDF
Article Synopsis
  • Neuroendocrine neoplasms (NENs) are uncommon in the head and neck, with laryngeal neuroendocrine carcinoma (NEC) being the most frequent, primarily affecting older men who smoke.
  • Approximately 700 cases have been documented, and the incidence rate is around 0.23%, leading to challenges in diagnosis and treatment due to their vague symptoms.
  • Treatment often combines surgery, chemotherapy, and radiotherapy, as illustrated by a case study of a 61-year-old female nonsmoker who received endoscopic excision and follow-up radiotherapy for supraglottic laryngeal NEC.
View Article and Find Full Text PDF

Laryngeal Paraganglioma with Neck Metastasis.

Indian J Otolaryngol Head Neck Surg

October 2024

Department of Otorhinolaryngology and Head and Neck Surgery, DR. PSIMS & RF, Chinnavutaplli, Gannavaram, Andhra Pradesh India.

Paragangliomas are neoplasms of neural crest cells. They represent less than 1% of head and neck tumors. Laryngeal paragangliomas constitute a smaller fraction of head and neck paragangliomas.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!